{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:41:24Z","timestamp":1772854884586,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.prp.2019.152651","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:15:04Z","timestamp":1568718904000},"page":"152651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait"],"prefix":"10.1016","volume":"215","author":[{"given":"Xiao-tong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-bing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-hao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-feng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng-hui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-yuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2019.152651_bib0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/modpathol.2010.213","article-title":"Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum","volume":"24","author":"Debelenko","year":"2011","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2019.152651_bib0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/gcc.20839","article-title":"ALK rearrangement in sickle cell trait-associated renal medullary carcinoma","volume":"50","author":"Marino-Enriquez","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"18","key":"10.1016\/j.prp.2019.152651_bib0015","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1002\/cncr.27391","article-title":"Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method","volume":"118","author":"Sugawara","year":"2012","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.prp.2019.152651_bib0020","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/modpathol.2012.107","article-title":"ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients","volume":"25","author":"Sukov","year":"2012","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2019.152651_bib0025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4132\/KoreanJPathol.2013.47.5.452","article-title":"ALK-positive renal cell carcinoma in a large series of consecutively resected korean renal cell carcinoma patients","volume":"47","author":"Lee","year":"2013","journal-title":"Korean J. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2019.152651_bib0030","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0000000000000179","article-title":"VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?","volume":"38","author":"Smith","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2019.152651_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/his.13185","article-title":"Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review","volume":"71","author":"Yu","year":"2017","journal-title":"Histopathology"},{"issue":"5151","key":"10.1016\/j.prp.2019.152651_bib0040","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.prp.2019.152651_bib0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9440(10)64550-6","article-title":"TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors","volume":"157","author":"Lawrence","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.prp.2019.152651_bib0050","first-page":"2776","article-title":"Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors","volume":"59","author":"Griffin","year":"1999","journal-title":"Cancer Res."},{"issue":"7153","key":"10.1016\/j.prp.2019.152651_bib0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.prp.2019.152651_bib0060","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.cell.2007.11.025","article-title":"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer","volume":"131","author":"Rikova","year":"2007","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.prp.2019.152651_bib0065","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1158\/1541-7786.MCR-08-0522","article-title":"Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers","volume":"7","author":"Lin","year":"2009","journal-title":"Mol. Cancer Res."},{"issue":"10","key":"10.1016\/j.prp.2019.152651_bib0070","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","article-title":"The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia","volume":"37","author":"Srigley","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2019.152651_bib0075","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/modpathol.2013.37","article-title":"Reply to\u2019 Distinct ALK-rearranged and VCL-negative papillary renal cell carcinoma variants in two adults without sickle cell trait\u2019","volume":"26","author":"Debelenko","year":"2013","journal-title":"Mod. Pathol."},{"issue":"18","key":"10.1016\/j.prp.2019.152651_bib0080","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.prp.2019.152651_bib0085","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/JTO.0b013e31821528d3","article-title":"Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification","volume":"6","author":"Ou","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2019.152651_bib0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.lungcan.2011.05.027","article-title":"ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity","volume":"75","author":"Kimura","year":"2012","journal-title":"Lung Cancer"},{"issue":"18","key":"10.1016\/j.prp.2019.152651_bib0095","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa1007056","article-title":"Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor","volume":"363","author":"Butrynski","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.prp.2019.152651_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018436","article-title":"Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas","volume":"6","author":"Cerchietti","year":"2011","journal-title":"PLoS One"},{"issue":"7728","key":"10.1016\/j.prp.2019.152651_bib0105","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-018-0621-1","article-title":"Transcription factor dimerization activates the p300 acetyltransferase","volume":"562","author":"Ortega","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.prp.2019.152651_bib0110","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1186\/s12885-018-4559-3","article-title":"p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells","volume":"18","author":"Hou","year":"2018","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.prp.2019.152651_bib0115","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.tranon.2019.08.004","article-title":"Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC)","volume":"12","author":"Lohinai","year":"2019","journal-title":"Transl. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2019.152651_bib0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081067","article-title":"EP300 and SIRT1\/6 Co-regulate lapatinib sensitivity via modulating FOXO3-acetylation and activity in breast cancer","volume":"11","author":"Mahmud","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2019.152651_bib0125","article-title":"Y08197 is a novel and selective CBP\/EP300 bromodomain inhibitor for the treatment of prostate cancer","author":"Zou","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.prp.2019.152651_bib0130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.5483\/BMBRep.2018.51.10.042","article-title":"TRRAP stimulates the tumorigenic potential of ovarian cancer stem cells","volume":"51","author":"Kang","year":"2018","journal-title":"BMB Rep."},{"issue":"6","key":"10.1016\/j.prp.2019.152651_bib0135","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1083\/jcb.201706106","article-title":"TRRAP is a central regulator of human multiciliated cell formation","volume":"217","author":"Wang","year":"2018","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.prp.2019.152651_bib0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.stem.2009.11.002","article-title":"An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation","volume":"6","author":"Wurdak","year":"2010","journal-title":"Cell Stem Cell"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819314025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819314025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:39:40Z","timestamp":1759732780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033819314025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0344033819314025"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2019.152651","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2019.152651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152651"}}